3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
21
Triple Negative Breast Neoplasms
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Neoplasm Metastasis
6
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasms
4
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Biliary Tract Neoplasms
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Resectable Pancreatic Cancer
1
Pancreatic Adenocarcinoma
1
Osteosarcoma
1
Neoplasms, Basal Cell
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Interventions
pembrolizumab
2
durvalumab
2
Nivolumab
2
Ipilimumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
balstilimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
Albumin-Bound Paclitaxel
×
90 days
×
Clear all
No trials found.